## Core Concept
The condition described is known as radiation recall reaction, a phenomenon where radiation therapy sensitizes tissues to the effects of certain chemotherapeutic agents, leading to an inflammatory response in previously irradiated areas. This reaction can occur days to months after radiation therapy.

## Why the Correct Answer is Right
The correct answer, **Doxorubicin**, is an anthracycline antibiotic that intercalates DNA strands, thereby inhibiting the synthesis of macromolecules and inducing apoptosis in cancer cells. It is well-known to cause radiation recall reactions. The mechanism behind this reaction involves the damage caused by radiation to the endothelial cells and the extracellular matrix, making the tissue more susceptible to the toxic effects of chemotherapeutic agents like doxorubicin.

## Why Each Wrong Option is Incorrect
- **Option A:** Although **Bleomycin** can cause skin reactions, it is more commonly associated with pulmonary toxicity and is not the most typical cause of radiation recall reactions compared to doxorubicin.
- **Option B:** **Cisplatin** is a platinum-based chemotherapeutic agent that can cause various side effects, including nephrotoxicity and neurotoxicity, but it is less commonly associated with radiation recall reactions.
- **Option D:** **Paclitaxel** is a taxane that can cause myelosuppression, neuropathy, and alopecia but is not commonly linked with radiation recall reactions.

## Clinical Pearl / High-Yield Fact
A key point to remember is that radiation recall reactions can be triggered by various chemotherapeutic agents, but **anthracyclines (like doxorubicin) and **actinomycin D** are among the most commonly implicated drugs**. Clinicians should be cautious when administering these drugs to patients with a history of recent radiation therapy.

## Correct Answer Line
**Correct Answer: C. Doxorubicin**.